JOSHUA BUCK: Open Payments
NPI 1205357977 · JOHNSON CITY, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,108 in 176 payments from 44 companies in 2025. Trend: 2023 $4,527 · 2024 $5,044 · 2025 $4,108
Food & beverage: $3,664Education: $278Long term medical supply or device loan: $167
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $437 |
| AstraZeneca Pharmaceuticals LP | 17 | $420 |
| Janssen Biotech, Inc. | 12 | $279 |
| Celgene Corporation | 12 | $232 |
| Incyte Corporation | 6 | $206 |
| Merck Sharp & Dohme LLC | 8 | $185 |
| E.R. Squibb & Sons, L.L.C. | 13 | $180 |
| Gilead Sciences, Inc. | 3 | $152 |
| Regeneron Healthcare Solutions, Inc. | 5 | $150 |
| Daiichi Sankyo Inc. | 6 | $142 |
Products named: KISQALI, REBLOZYL, KEYTRUDA, Enhertu, Trodelvy, ERLEADA, LIBTAYO, OPDIVO.
Industry payments across TN — which companies pay providers there.
